Crossmark

Exocrine Pancreatic Insufficiency Dosing Guidelines for Pancreatic Enzyme Replacement Therapy Vary Widely Across Disease Types

Crossref DOI link: https://doi.org/10.1007/s10620-023-08184-w

Published Online: 2023-12-20

Published Print: 2024-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lewis, Dana M. https://orcid.org/0000-0001-9176-6308
Rieke, Jorden G. https://orcid.org/0000-0001-6813-9699
Almusaylim, Khaleal https://orcid.org/0009-0009-0131-3619
Kanchibhatla, Anuhya https://orcid.org/0009-0002-7181-9809
Blanchette, Julia E. https://orcid.org/0000-0002-6714-4792
Lewis, Claudia https://orcid.org/0000-0002-7643-7693
License Information

Text and Data Mining valid from 2023-12-20

Version of Record valid from 2023-12-20
More Information

Article History

Received: 26 June 2023

Accepted: 6 November 2023

First Online: 20 December 2023

Declarations

:

: The authors declare no financial conflict of interest.